Premium
Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis
Author(s) -
Rudmik Luke,
Smith Timothy L.,
Mace Jess C.,
Schlosser Rodney J.,
Hwang Peter H.,
Soler Zachary M.
Publication year - 2016
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.25656
Subject(s) - medicine , presenteeism , absenteeism , productivity , refractory (planetary science) , chronic rhinosinusitis , observational study , sick leave , surgery , physical therapy , physics , management , astrobiology , economics , macroeconomics
Objectives/Hypothesis The primary objective of this pilot study was to define the change in productivity costs following endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS). Secondary objectives were to identify CRS‐related characteristics that may influence the degree of productivity improvement after ESS. Study Design Prospective, multi‐institutional, observational cohort study. Methods The human capital approach was used to define productivity costs. Annual absenteeism, presenteeism, and lost leisure time were quantified to define annual lost productive time (LPT). LPT was monetized using the annual daily wage rates obtained from the 2012 US Census and the 2013 US Department of Labor statistics. Results Twenty‐seven patients with refractory CRS who underwent ESS were followed for a mean of 15 months (range, 8–25 months). Following ESS, there were improvements in annual absenteeism (22 days reduced to 3 days), annual presenteeism (41 days reduced to 19 days), and annual household days lost (12 days reduced to 6 days). Overall, the preoperative productivity costs were reduced after ESS ($9,190 vs. $3,373, respectively; P < .001). Conclusions Daily productivity is negatively impacted by the presence of CRS. The outcomes from this study provide the first insights into the reduced productivity costs associated with receiving ESS for refractory CRS. Future studies with larger sample sizes will need to validate the results from this pilot study. Level of Evidence 2c Laryngoscope , 126:570–574, 2016